+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Diarrheal"

Diarrhea (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Diarrhea (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Irritable Bowel Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 194 Pages
  • Global
From
Traveler's Diarrhea - Epidemiology Forecast to 2032 - Product Thumbnail Image

Traveler's Diarrhea - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Gastroenteritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Gastroenteritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 103 Pages
  • Global
From
Diarrhea - Pipeline Review, H2 2020 - Product Thumbnail Image

Diarrhea - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 156 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Anti Diarrheal market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Anti Diarrheal drugs are used to treat diarrhea, which is a common symptom of many gastrointestinal disorders. These drugs work by reducing the amount of water and electrolytes lost in the stool, and by slowing down the movement of the intestines. Commonly used Anti Diarrheal drugs include loperamide, diphenoxylate, and bismuth subsalicylate. The Anti Diarrheal market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Johnson & Johnson, and Novartis. Other companies in the market include Sanofi, Bayer, AstraZeneca, and Daiichi Sankyo. Show Less Read more